Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Comparison of clot-based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research Study.

Miller CH, Rice AS, Boylan B, Shapiro AD, Lentz SR, Wicklund BM, Kelly FM, Soucie JM; Hemophilia Inhibitor Research Study Investigators.

J Thromb Haemost. 2013 Jul;11(7):1300-9. doi: 10.1111/jth.12259.

2.

Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance.

Miller CH, Platt SJ, Rice AS, Kelly F, Soucie JM; Hemophilia Inhibitor Research Study Investigators.

J Thromb Haemost. 2012 Jun;10(6):1055-61. doi: 10.1111/j.1538-7836.2012.04705.x.

3.

Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors.

Miller CH, Boylan B, Shapiro AD, Lentz SR, Wicklund BM; Hemophilia Inhibitor Research Study Investigators.

J Thromb Haemost. 2017 Oct;15(10):1971-1976. doi: 10.1111/jth.13795. Epub 2017 Sep 14.

4.

Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.

Boylan B, Rice AS, Dunn AL, Tarantino MD, Brettler DB, Barrett JC, Miller CH; Hemophilia Inhibitor Research Study Investigators; Hemophilia Inhibitor Research Study Investigators.

J Thromb Haemost. 2015 Jan;13(1):47-53. doi: 10.1111/jth.12768. Epub 2014 Dec 11.

5.

Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening.

Miller CH, Rice AS, Boylan B, Payne AB, Kelly FM, Escobar MA, Gill J, Leissinger C, Soucie JM; Hemophilia Inhibitor Research Study Investigators.

Am J Hematol. 2015 Oct;90(10):871-6. doi: 10.1002/ajh.24104. Epub 2015 Sep 10.

6.

[Comparison of modified Bethesda assay and Nijmegen assay in detecting FVII inhibitor in patients with hemophilia A].

Fan LK, Wang ZW, Hua BL, Su W, Wang SJ, Zhao YQ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2009 Oct;31(5):551-4. Chinese.

7.

Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.

Werwitzke S, Geisen U, Nowak-Göttl U, Eichler H, Stephan B, Scholz U, Holstein K, Klamroth R, Knöbl P, Huth-Kühne A, Bomke B, Tiede A.

J Thromb Haemost. 2016 May;14(5):940-7. doi: 10.1111/jth.13304. Epub 2016 Apr 22.

8.

Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A.

Batty P, Moore GW, Platton S, Maloney JC, Palmer B, Bowles L, Pasi KJ, Rangarajan S, Hart DP.

Thromb Haemost. 2015 Oct;114(4):804-11. doi: 10.1160/TH14-12-1062. Epub 2015 Jun 11.

PMID:
26063073
9.

Alloantibodies to factor VIII in haemophilia.

Zakarija A, Harris S, Rademaker AW, Brewer J, Krudysz-Amblo J, Butenas S, Mann KG, Green D.

Haemophilia. 2011 Jul;17(4):636-40. doi: 10.1111/j.1365-2516.2010.02468.x. Epub 2011 Feb 7.

PMID:
21299745
10.

Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects.

Batlle J, Gómez E, Rendal E, Torea J, Lourés E, Couselo M, Vila P, Sedano C, Tusell X, Magallón M, Quintana M, González-Boullosa R, López-Fernández MF.

Ann Hematol. 1996 May;72(5):321-6.

PMID:
8645745
11.

Validation of 4% albumin as a diluent in the Bethesda Assay for FVIII inhibitors.

Kershaw GW, Chen LS, Jayakodi D, Dunkley SM.

Thromb Res. 2013;132(6):735-41. doi: 10.1016/j.thromres.2013.09.018. Epub 2013 Sep 21.

PMID:
24119613
12.

[Modified Bethesda, modified Nijmegen and blank assays for coagulation factor VIII inhibitor detection and factors affecting the results].

Feng HM, Li Q, Xu WS, Chen DM, Zheng L.

Nan Fang Yi Ke Da Xue Xue Bao. 2016 Apr;36(4):592-5. Chinese.

PMID:
27113194
13.

Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay.

Boylan B, Rice AS, Neff AT, Manco-Johnson MJ, Kempton CL, Miller CH; Hemophilia Inhibitor Research Study Investigators.

J Thromb Haemost. 2016 Oct;14(10):1931-1940. doi: 10.1111/jth.13438. Epub 2016 Sep 17.

14.

Nijmegen-Bethesda assay to measure factor VIII inhibitors.

Duncan E, Collecutt M, Street A.

Methods Mol Biol. 2013;992:321-33. doi: 10.1007/978-1-62703-339-8_24.

PMID:
23546724
15.

Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.

Towfighi F, Gharagozlou S, Sharifian RA, Kazemnejad A, Esmailzadeh K, Managhchi MR, Shokri F.

Acta Haematol. 2005;114(2):84-90.

PMID:
16103630
16.

Inhibitor development in non-severe haemophilia across Europe.

Fischer K, Iorio A, Lassila R, Peyvandi F, Calizzani G, Gatt A, Lambert T, Windyga J, Gilman EA, Hollingsworth R, Makris M; EUHASS Participants.

Thromb Haemost. 2015 Oct;114(4):670-5. doi: 10.1160/TH14-12-1044. Epub 2015 Aug 13. Erratum in: Thromb Haemost. 2016 Mar;115(3):684. Hollingsworth, R [Added].

PMID:
26293381
17.

Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.

Luna-Záizar H, Beltrán-Miranda CP, Esparza-Flores MA, Soto-Padilla J, Bergés-García A, Rodríguez-Zepeda MD, Pompa-Garza MT, Jaloma-Cruz AR.

Haemophilia. 2014 Jan;20(1):e7-14. doi: 10.1111/hae.12309.

PMID:
24354488
18.

Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.

Kraiem I, Hadhri S, El Omri H, Sassi R, Chaabani W, Ennabli S, Skouri H.

Ann Biol Clin (Paris). 2012 Nov-Dec;70(6):659-65. doi: 10.1684/abc.2012.0765.

19.

Expanding the ortholog approach for hemophilia treatment complicated by factor VIII inhibitors.

Zakas PM, Vanijcharoenkarn K, Markovitz RC, Meeks SL, Doering CB.

J Thromb Haemost. 2015 Jan;13(1):72-81. doi: 10.1111/jth.12755. Epub 2014 Nov 11.

20.

A critical appraisal of one-stage and chromogenic assays of factor VIII activity.

Peyvandi F, Oldenburg J, Friedman KD.

J Thromb Haemost. 2016 Feb;14(2):248-61. doi: 10.1111/jth.13215. Epub 2016 Feb 1. Review.

Supplemental Content

Support Center